Advanced Neuroscience Network Team Presents on Innovations in Stroke CareFeb 12, 2020
Advanced Neuroscience Network team meets with local fire chiefs and EMS personnel
Miami Dade County, Fla. (March 30, 2015) – The Advanced Neuroscience Network (ANN), part of Tenet Healthcare’s Florida region, gave a series of presentations at the Miami-Dade Stroke Coordinators and EMS meeting in March.
Over 50 people attended the meeting, including hospital stroke teams and physicians on staff at 13 Miami-Dade County hospitals, in addition to Miami-Dade EMS, the Fire Officers Association of Miami-Dade and the American Heart Association. The objective is to provide a platform for hospital stroke teams to focus on process improvement specific to stroke care. The ultimate goal is to foster an environment that would identify, assess and provide relevant educational solutions.
Sharon Pardo, stroke coordinator at Good Samaritan Medical Center in West Palm Beach, spoke about Tenet’s nationwide Door-to-Needle Challenge. ANN was also honored with the opportunity to present this information at the International Stroke Conference in February.
The goal of the 18-month challenge, which launched in 2013, was to reduce the amount of time for patients to receive tissue plasminogen activator (tPA), a clot-busting drug that restores blood flow to the brain. As a result, the number of stroke patients receiving the rapid treatment at Tenet hospitals throughout the country increased by 20 percent. Seventy percent of patients at those hospitals were able to have the intravenous drug delivered within one hour of arrival, exceeding the national rate of 30 percent.
Additionally, interventional neurologist, Dr. Ritesh Kaushal, discussed the growth of Palmetto General Hospital’s Comprehensive Stroke Center and what the staff has done to decrease door-to-needle time over the last two years. In January and February of this year, the team achieved an average 27-minute door-to-needle time with an astounding low of only 10 minutes.
Dr. Nils Mueller-Kronast, regional medical director of ANN, also presented updates on the clinical trial, “MR CLEAN.” As published online in the New England Journal of Medicine, the results of the Multicenter Randomized Clinical trial of Endovascular treatment for Acute ischemic stroke in the Netherlands (MR CLEAN) Trial determined that intra-arterial treatment (IAT), in conjunction with tissue plasminogen activator (tPA), is significantly more effective than administering tPA alone.
“We are focused on developing systems of care because time is brain,” said Dr. Mueller. “For every 30-minute delay in intra-arterial therapy, we lose 14 percent of treatment effect.”
ANN’s Delray Medical Center, Florida Medical Center, Palmetto General Hospital and St. Mary’s Medical Center are four of the leading Comprehensive Stroke Centers in South Florida, dedicated to providing patients with the highest level of stroke care. They have all received the prestigious designation as Target: Stroke Honor Roll members by the American Heart Association/American Stroke Association.